EN
HI
Summary
As of 11 Sep, 2026, Accretion Pharmaceuticals stock price is ₹215. During the trading session, the stock has moved between an intraday low of ₹207.55 and an intraday high of ₹215.00. Over the last 52 weeks, Accretion Pharmaceuticals has traded between ₹53.80 and ₹215.00.
The stock has recorded a trading volume of 13,200 shares,. Its Average Traded Price (ATP) is ₹211.61, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 3600 @ ₹215.00.
Accretion Pharmaceuticals has an upper circuit limit of ₹220.50 and a lower circuit limit of ₹199.50. The total value traded stands at ₹27.93 L, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 1200. Accretion Pharmaceuticals also offers a dividend yield of 0%.
Accretion Pharmaceuticals Share Price Chart
Accretion Pharmaceuticals Share Key Metrics
Volume
13200.00
Market Cap
233.44 CR
LTQ@LTP
3600@215.00
ATP
211.61
Var Margin
100 %
Circuit Range
199.5-220.5
Delivery %
100 %
Value
27.93 L
ASM/GSM
No
Market Lot
1200
Accretion Pharmaceuticals Resistance and Support
Pivot 207.18
Resistance
First Resistance
212.81
Second Resistance
215.63
Third Resistance
221.26
Support
First Support
204.36
Second Support
198.73
Third Support
195.91
Accretion Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 11 2026 | 207.6 | 215 | 2.38% | 215 | 207.55 |
| Thu Sep 10 2026 | 201.55 | 210 | 3.96% | 210 | 201.55 |
| Wed Sep 09 2026 | 205 | 202 | -3.81% | 210 | 201 |
Accretion Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-08 | Audited Results & Others |
Accretion Pharmaceuticals Management
| Name | Position |
|---|---|
| Harshad Nanubhai Rathod | Chairman & Chief Financial Officer |
| Vivek Ashok Kumar Patel | Managing Director |
Accretion Pharmaceuticals FAQs
The Buying Price of Accretion Pharmaceuticals share is 215 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Accretion Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Accretion Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Accretion Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Accretion Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Accretion Pharmaceuticals’s valuation compare Sector P/E, P/B which are 41.56 & 3.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Accretion Pharmaceuticals is 233.44 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Accretion Pharmaceuticals share price is 215.00 & 53.80. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Accretion Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ACCPL
